Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

China flag China · Delayed Price · Currency is CNY
92.24
+1.40 (1.54%)
At close: Dec 5, 2025
15.11%
Market Cap 32.54B
Revenue (ttm) 6.29B
Net Income (ttm) 1.04B
Shares Out 359.15M
EPS (ttm) 2.86
PE Ratio 32.23
Forward PE 25.30
Dividend 1.10 (1.21%)
Ex-Dividend Date Jun 26, 2025
Volume 2,704,405
Average Volume 3,275,375
Open 90.77
Previous Close 90.84
Day's Range 90.60 - 92.27
52-Week Range 59.90 - 125.50
Beta 0.31
RSI 42.88
Earnings Date Apr 1, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002821
Full Company Profile

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial Statements

News

There is no news available yet.